Justin Hanka | Source | Co-Founder & Director at MindBio Therapeutics
Justin Hanka
Justin Hanka takes companies public, raises venture capital, leads capital markets private placements and is an expert in local and cross border M&A transactions.
He is a fund investment manager of NAFUND1 (a North American pre-IPO investment fund) and a fund investment manager for ECMP Fund (an equity capital markets placement fund).
Justin is an expert in preparing founders and their businesses for listing on the capital markets and executing M&A transactions.
Justin co-founded MindBio Therapeutics, a clinical stage biotechnology company to change the course of mental health treatment
-
MindBio Therapeutics (https://www.mindbiotherapeutics.com/)
Co-Founder & Director
started May 2021
-
The NYSE and Nasdaq have become the hottest clubs in New York. Here’s why.
To hear financial professionals tell it, the key difference between the two major trading platforms — the New York Stock Exchange and Nasdaq — has to do with their history.
Article -
New Research Shows Micro-Dosing LSD Improves Sleep Duration: Experts Weigh In | Sleepopolis
Research into psychedelics and their effects on the broad spectrum of our health and wellness has apparently been a thing since 1955. (1) If we scour the
Article
